An observational study in Carpal Tunnel Syndrome (CTS), sponsored by University of British Columbia. Enrolling by invitation at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-26.
Sponsored by University of British Columbia · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Carpal Tunnel Syndrome with a site in Canada — 4 open to participants now, 4 under way, none of them phase 3. Carpal Tunnel Syndrome · Canada.
Among the 16 studies in Carpal Tunnel Syndrome with a site in Canada, this one is the only one that started in 2025, is the only observational one, and was the 15th registered.
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
Browse Carpal Tunnel Syndrome studies →4 of the 16 studies in Carpal Tunnel Syndrome with a site in Canada are open now. Recruiting first, the newest first:
University of Manitoba · Sites in Canada
Ages 18+
TOPMED · Sites in Canada
Ages 18–70
Emily Krauss · Sites in Canada
Ages 18+ · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 4 · Phase 3 1 · Phase 4 2
First in 2006; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 92 across 131 observational studies indexed under Carpal Tunnel Syndrome.
Median enrollment 60 across the 15 interventional studies, 200 across the 1 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 10 most frequent:
University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
University of British Columbia has 2 studies filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Carpal Tunnel Syndrome with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07544914University of ManitobaEffects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain | 2027-08-30 |
Add it to your calendar (.ics) → With an account.
Among the 16 studies in Carpal Tunnel Syndrome with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are:
Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change.
Participants will be asked to complete a short patient satisfaction survey.
Retrospective: Patients age 18 or over seen by study surgeons for CTS. Prospective: patients age 18 or over with carpal tunnel syndrome seen at SPH or Vancouver Hospital EMG lab.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm were treated for carpal tunnel syndrome before the Carpal Tunnel Plus Pathway was implemented.
Participants in this arm were treated for carpal tunnel syndrome after the Carpal Tunnel Plus Pathway was implemented.
Procedure: Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)
Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons.
Wait times
Time between each step of the care pathway (e.g. from referral to EMG/neurologic consultation, from referral to surgical consultation, from surgical consultation to surgery)
Time frame: From initial referral to surgery/injection (variable, but approximately 9 months)
Patient satisfaction
Patients will be asked to complete a short questionnaire to indicate their level of satisfaction with the care that they received. The custom survey will consist of 4 questions on various aspects of their care that participants will rate on a scale of 1-5 (1 = not at all satisfied, 5 = very satisfied).
Time frame: Immediately after surgery/injection appointment
Plan to share: No — Individual participant data will not be shared. Only group averages/summary measures will be included in any publications.
Started Feb 2025 (actual). Primary completion is estimated for Mar 2026, 13 months after the start.
Of 40 non-industry observational studies under Carpal Tunnel Syndrome, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 13 months is close to that.
Counting every sponsor, half of 42 studies reached it within 18 months; a quarter within 11 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →